Aclaris Therapeutics Correlations

ACRS Stock

USD 1.60 0.03 1.91%

The correlation of Aclaris Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Aclaris Therapeutics Correlation With Market

Average diversification

The correlation between Aclaris Therapeutics and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aclaris Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclaris Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Aclaris Stock please use our How to Invest in Aclaris Therapeutics guide.

Moving together with Aclaris Stock

0.88	CDIOW	Cardio Diagnostics	Pair Corr
0.74	VINC	Vincerx Pharma Earnings Call This Week	Pair Corr
0.65	ELEV	Elevation Oncology	Pair Corr
0.74	ELVN	Enliven Therapeutics	Pair Corr
0.86	GPCR	Structure Therapeutics	Pair Corr
0.82	ZURA	Zura Bio Limited	Pair Corr
0.75	IMMX	Immix Biopharma	Pair Corr
0.86	MLTX	MoonLake Immunotherapeuti	Pair Corr
0.83	PMVP	Pmv Pharmaceuticals	Pair Corr
0.88	PYXS	Pyxis Oncology	Pair Corr
0.82	SCLX	Scilex Holding	Pair Corr
0.79	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.78	ATNF	180 Life Sciences	Pair Corr
0.61	SONN	Sonnet Biotherapeutics	Pair Corr

Moving against Aclaris Stock

0.9	SNY	Sanofi ADR	Pair Corr
0.87	AZN	AstraZeneca PLC ADR	Pair Corr
0.83	OCX	OncoCyte Corp	Pair Corr
0.83	GILD	Gilead Sciences	Pair Corr
0.78	GOSS	Gossamer Bio	Pair Corr
0.63	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.55	LLY	Eli Lilly	Pair Corr
0.5	PLX	Protalix Biotherapeutics	Pair Corr
0.86	AMGN	Amgen Inc	Pair Corr
0.81	NVCT	Nuvectis Pharma	Pair Corr
0.64	DRMAW	Dermata Therapeutics	Pair Corr
0.37	CMPX	Compass Therapeutics	Pair Corr
0.33	RVP	Retractable Technologies Earnings Call This Week	Pair Corr

Related Correlations Analysis

	NEOG	QGEN	OLK	SYNH	SHC	RDNT	MYGN	GTH	BDSX	CSTL
NEOG		0.9	0.0	0.0	0.59	0.86	0.69	0.0	0.88	0.74	NEOG
QGEN	0.9		0.0	0.0	0.53	0.74	0.55	0.0	0.76	0.63	QGEN
OLK	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	OLK
SYNH	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	SYNH
SHC	0.59	0.53	0.0	0.0		0.76	0.76	0.0	0.5	0.86	SHC
RDNT	0.86	0.74	0.0	0.0	0.76		0.84	0.0	0.87	0.89	RDNT
MYGN	0.69	0.55	0.0	0.0	0.76	0.84		0.0	0.68	0.87	MYGN
GTH	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	GTH
BDSX	0.88	0.76	0.0	0.0	0.5	0.87	0.68	0.0		0.69	BDSX
CSTL	0.74	0.63	0.0	0.0	0.86	0.89	0.87	0.0	0.69		CSTL
	NEOG	QGEN	OLK	SYNH	SHC	RDNT	MYGN	GTH	BDSX	CSTL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

QGEN	+ 0.9	NEOG
CSTL	+ 0.89	RDNT
BDSX	+ 0.88	NEOG
BDSX	+ 0.87	RDNT
CSTL	+ 0.87	MYGN
RDNT	+ 0.86	NEOG

High negative correlations

CSTL	- 0.0	GTH
BDSX	- 0.0	GTH
GTH	- 0.0	MYGN
GTH	- 0.0	RDNT
GTH	- 0.0	SHC
CSTL	- 0.0	SYNH

Risk-Adjusted Indicators

There is a big difference between Aclaris Stock performing well and Aclaris Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aclaris Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Treynor Ratio	Potential Upside	Value @Risk	Maximum Drawdown
NEOG	2.03	(0.42)	(0.90)	3.92	(5.06)	12.07
QGEN	1.12	(0.18)	(0.65)	2.59	(3.00)	6.36
OLK	0.00	0.00	0.00	0.00	0.00	0.00
SYNH	0.00	0.00	0.00	0.00	0.00	0.00
SHC	1.42	(0.07)	(0.14)	2.40	(2.88)	12.51
RDNT	2.12	(0.60)	(0.63)	4.64	(5.11)	14.21
MYGN	2.55	(0.45)	(0.72)	4.14	(5.34)	26.72
GTH	0.00	0.00	0.00	0.00	0.00	0.00
BDSX	3.68	(0.48)	(0.49)	7.89	(8.87)	29.63
CSTL	2.52	(0.44)	(1.89)	4.51	(6.33)	23.81

Aclaris Therapeutics Corporate Executives

Elected by the shareholders, the Aclaris Therapeutics' board of directors comprises two types of representatives: Aclaris Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aclaris. The board's role is to monitor Aclaris Therapeutics' management team and ensure that shareholders' interests are well served. Aclaris Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aclaris Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

Frank Ruffo

CFO CoFounder

Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC